Tenzing Acquisition Corp. in its latest filing set a shareholder vote for Dec. 8 on the proposed merger with Reviva, a California-based clinical stage pharmaceutical company. If approved, the merger would give the combined companies a valuation of $119M. Read more.
Tenzing Acquisition Corp. Sets Vote Date for Reviva Pharmaceuticals Merger
